People: Abbott Laboratories (ABT)

ABT on New York Consolidated

49.41USD
2 Jul 2015
Change (% chg)

$-0.11 (-0.22%)
Prev Close
$49.52
Open
$49.80
Day's High
$49.82
Day's Low
$49.16
Volume
2,740,289
Avg. Vol
4,628,542
52-wk High
$50.47
52-wk Low
$39.28

Search Stocks

Capek, John 

Dr. John M. Capek, Ph.D. has been appointed as Executive Vice President - Ventures of the Company, effective June 1, 2015. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Basic Compensation

Total Annual Compensation, USD 1,350,610
Restricted Stock Awards, USD 904,024
Long-Term Incentive Plans, USD --
All Other, USD 1,544,760
Fiscal Year Total, USD 3,799,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Miles White

17,732,200

Brian Yoor

--

Thomas Freyman

7,307,830

Hubert Allen

3,772,840

Stephen Fussell

5,750,460

Richard Ashley

3,640,640
As Of  30 Dec 2014
Search Stocks